GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Net Issuance of Debt

New Horizon Health (HKSE:06606) Net Issuance of Debt : HK$331 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. New Horizon Health's net issuance of debt for the six months ended in Jun. 2023 was HK$219 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Jun. 2023 was HK$331 Mil.

New Horizon Health Net Issuance of Debt Historical Data

The historical data trend for New Horizon Health's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health Net Issuance of Debt Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Net Issuance of Debt
- 56.19 77.92 -44.98 112.23

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only -44.38 - - 112.23 218.76

New Horizon Health Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$331 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Horizon Health Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of New Horizon Health's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

New Horizon Health (HKSE:06606) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Net Issuance of Debt
Comparable Companies
HKSE:01789 HKSE:09877 HKSE:02172 HKSE:02291 HKSE:01858 HKSE:01302 HKSE:02407 HKSE:09996 HKSE:06922 HKSE:02160 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
6YZ:Germany
Address
400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
Website
https://ir.newhorizonbio.com
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.

New Horizon Health (HKSE:06606) Headlines

No Headlines